Loss of circadian BP change has been linked to target organ damage and accelerated kidney function loss in hypertensive patients with and without chronic kidney disease. Ambulatory BP-derived data from 119 consecutive kidney transplant recipients who presented for the first annual evaluation were examined in relation to allograft function, histology, and ultrasound findings. A total of 101 (85%) patients were receiving antihypertensive medications (median 2), and 85 (71%) achieved target awake average systolic BP (SBP) of <135 mmHg. A day-night change in SBP by 10% or more (dippers) was detected in 29 (24%). Dipping status was associated with younger recipient age, lack of diabetes, low chronic vascular score, and low resistive index. Nondippers and reverse dippers had lower GFR compared with dippers (P ‫؍‬ 0.04). For every 10% nocturnal drop in SBP, GFR increased by 4.6 ml/min per 1.73 m 2 (R ‫؍‬ 0.3, P ‫؍‬ 0.003). Nondippers and reverse dippers were equally common in recipients with normal histology and in those with pathologic findings on surveillance biopsy. On multivariate analysis, percentage of nocturnal fall in SBP and elevated resistive index independently correlated with GFR. This study indicates that lack of nocturnal fall in SBP is related to poor allograft function, high chronic vascular score, and high resistive index irrespective of allograft fibrosis. Further studies are needed to determine whether restoration of normal BP pattern will confer better allograft outcome.
is not consistently achieved. Failure to have a circadian fall in BP is designated as a "nondipper" status. Nondippers have more severe target injury, including a higher rate of strokes, dementia, left ventricular hypertrophy, and microalbuminuria (4 -6) . Even with normal average pressure levels, nondippers with type 1 diabetes are more likely to develop diabetic nephropathy during subsequent years (7) . Studies suggest that nondipping accelerates loss of GFR in individuals with and without chronic kidney disease (CKD) (8, 9) . Previous studies indicated that disturbances in circadian BP patterns develop in liver, kidney, and cardiac transplant recipients, sometimes persisting for several years (10 -12) .
Resistive index (RI) is promoted as a general marker of vascular compliance (13, 14) . In kidney transplant recipients, elevated RI is a predictor of renal allograft survival and death from cardiovascular disease (15) . However, elevated RI is not necessarily related to biopsy findings, which leaves open the question of how elevated RI is involved in allograft dysfunction (16) .
We sought to evaluate BP measurements systematically in mostly treated transplant recipients who returned for scheduled review of renal allograft function 1 yr after transplantation. Theses studies included routine clinic BP measurements (Dinamap), standardized BP protocols using American Heart Association (AHA) trained nurses, and ambulatory BP monitoring (ABPM) with day and night segments. Additional studies included measurement of GFR by iothalamate clearance, histologic assessment with surveillance biopsy, and ultrasound evaluation of the allograft. We wished to examine the hypothesis that circadian BP measurements relate to allograft function, RI and histologic findings even at this relatively early time point.
Materials and Methods

Study Population
Included in this analysis were 119 consecutive kidney transplant recipients who underwent ABPM between August 2004 and August 2005 as part of their first annual posttransplantation evaluation. Review and analysis of the clinical records from these patients was undertaken with the approval from the Mayo Institutional Review Boards. ABPM was obtained using an overnight automated ABPM monitor (Spacelabs, Issaquah, WA) as described previously (11) . Briefly, the 18-h monitoring period was selected to determine awake and inactive nocturnal BP profiles without interfering with other posttransplantation studies during morning and early afternoon. Each monitor consisted of an appropriately sized inflatable cuff, worn on the nondominant arm. BP was measured automatically and stored every 10 min during awake hours and every 20 min during nocturnal hours. Two 5-h period blocks for awake and nocturnal measurements were selected for the analysis. A 2-h interval between the awake and nocturnal data periods was excluded from analysis to eliminate the variable effects of sleep initiation (17) . For ensuring accuracy, BP measurements were calibrated against manual auscultatory measurements at the outset by trained technicians. On the basis of percentage reduction in the circadian BP, patients were grouped into dippers (⌬SBP Ն10%), nondippers (⌬SBP between 0 and 9%), or reverse dippers (nocturnal rise in SBP). Clinic BP measurements were obtained by clinic staff using an automated oscillometric device (Dinamap; Critikon, Tampa, FL), during a quiet sitting at a recording station. Standardized BP was obtained by a hypertension therapy nurse who was trained to apply AHA standards regarding patient positioning and measurement of auscultatory BP. Care was taken to ensure at least 5 min of quiet rest, using AHA standards for arm support, cuff size, and body positioning (18) . The mean of three seated BP measurements was recorded. Body surface area and body mass index were determined using height and weight measurements.
Graft function was assessed by serum creatinine and GFR determination using the clearance of subcutaneous nonradiolabeled iothalamate during water diuresis (19) . Results were corrected for body surface area and expressed as ml/min per 1.73 m 2 . A total of 109 recipients had iothalamate GFR values available at both 3 wk and 1 yr after transplantation. GFR was estimated by 24-h urinary creatinine clearance in another four patients. Urinary protein and microalbumin excretion was measured from a 24-h urine collection. Transplant renal ultrasound including segmental Doppler flow velocities was undertaken in 117 patients. RI at the arcuate arteries was determined at the upper, middle, and lower zones using the formula [peak systolic velocity Ϫ end diastolic velocity/peak systolic velocity]. The results from the three readings were averaged and recorded. A percutaneous allograft surveillance biopsy was obtained on 112 recipients. These biopsies were obtained as part of the routine care of renal transplant patients at Mayo Clinic, Rochester, and were not related to graft dysfunction. Biopsy specimens were evaluated by routine light microscopy by an experienced renal pathologist and were scored using the Banff '97 classification (20) . For the purpose of this analysis, acute and chronic scores for inflammation and tubular injury were combined (iϩt and ciϩct). Data regarding recipient's demographics, donor characteristics (donor age and gender), type and dosage of immunosuppression medications, and type of hypertensive medications were obtained from patients' charts and electronic medical records. Recipients with biopsyproven acute rejection episodes and polyomavirus-associated nephropathy (PVAN) diagnosed in the first posttransplantation year were identified. PVAN diagnosis was based on the demonstration of BKV DNA by in situ hybridization performed on paraffin-embedded sections as described previously (21) . Immunosuppression consisted of intravenous methylprednisolone for 4 d. Induction therapy with rabbit anti-thymocyte globulin 1.5 mg/kg per d for a total of four to six doses was given in 117 followed by oral immunosuppression with prednisone tapered to 5 mg/d by 3 mo, mycophenolate mofetil 750 mg twice daily and either tacrolimus (target trough level 10 to 12 ng/ml [Abbott IMX whole-blood assay] for 3 mo and 6 to 8 ng/ml thereafter) or sirolimus (target trough level 15 to 20 mg/ml for 3 mo and 8 to 15 ng/ml thereafter). Two patients received FTY-720 followed by prednisone and microemulsion cyclosporine.
Statistical Analyses
Results are presented as counts and percentages for qualitative data and means and SD for quantitative data. Means of normally distributed data were compared by t test and for more than two groups by ANOVA. Data that were not normally distributed were compared by nonparametric tests. 2 
Results
Demographic information, including age, gender, body mass index and pretransplantation clinical features, iothalamate GFR 3 wk after transplantation, and donor information, for the 119 studied patients is summarized in Table 1 . The study cohort consisted mainly of white patients, and the majority (76%) received a living-donor kidney transplant. The mean GFR at 3 wk was 56.6 Ϯ 16.0 ml/min per 1.73 m 2 . Table 2 summarizes clinical information that was obtained at the visit 1 yr after transplantation. The predominant immunosuppressive regimen was prednisone, tacrolimus, and mycophenolate mofetil (92%), and the mean GFR was 58.5 Ϯ 17.8 ml/min per 1.73 m 2 . At the time of ABPM evaluation, 101 (85%) recipients were receiving antihypertensive therapy that consisted of a median of two BP medications (range 1 to 5).
Target BP (defined as awake average SBP Ͻ135 mmHg) was achieved in the majority (71%) of patients. Clinic BP were higher than either ABPM or standardized BP values (P Ͻ 0.001 for both), whereas awake average SBP was not different from standardized SBP readings (NS). Forty-one percent of clinic BP levels were considered above target, whereas 29% of awake ABPM values failed to reach BP goal.
On the basis of the circadian change in SBP, 29 (24%) patients were dippers (mean Ϯ SD ⌬SBP 13.7 Ϯ 3.8%), 50 (42%) were nondippers (mean Ϯ SD ⌬SBP change 5.2 Ϯ 2.4%), and 40 (34%) were reverse dippers (mean Ϯ SD ⌬SBP change Ϫ9.1 Ϯ 8.4%). ABPM-derived BP measurements and clinical characteristics for patients within these groups are summarized in Tables 3 and 4 . Office BP readings did not regularly relate to dipper status. SBP was higher only in the reverse dipper group, but other SBP and DBP readings did not differ. The dipper status in transplant recipients reflected both progressively lower awake readings (see Table 3 for both SBP and DBP) and progressively higher nocturnal readings. Factors that were associated with a dipper status included younger recipient age and low arcuate artery RI. Absence of diabetes and lower chronic vascular (cv) score trended to associate with dipper status but did not reach statistical significance (P ϭ 0.06 and 0.07, respectively). The type of transplant, preemptive transplantation, recipient gender, calcineurin inhibitor-free immunosuppression, average trough tacrolimus level, class of antihypertensive medications, the degree of proteinuria, donor age, and donor gender did not correlate with the circadian BP rhythm.
Relationship between Circadian BP Change and 1-Yr GFR
Iothalamate GFR did not differ between dippers and the other two groups at an early (3 wk) time point. When measured 1 yr after transplantation, nondippers and reverse dippers had lower GFR compared with dippers (iothalamate clearance for dippers was 64.1 Ϯ 21.5 ml/min per 1.73 m 2 , for nondippers was 59.5 Ϯ 16.9 ml/min per 1.73 m 2 , and for reverse dippers was 53.2 Ϯ 14.5 ml/min per 1.73 m 2 ; P ϭ 0.04; Figure 1) . The relationship between GFR as measured by iothalamate clearance and the percentage of day-night SBP change is demonstrated in Figure 2 . Iothalamate clearance correlated with the percentage of nocturnal fall in SBP (R ϭ 0.3, P ϭ 0.003). For every 10% nocturnal drop from the awake average SBP, GFR increased by 4.6 ml/min per 1.73 m 2 .
Relationship between Nocturnal Fall in SBP, GFR, and Pathologic Findings 1 Yr after Transplantation
To determine whether the correlation between percentage of nocturnal fall in SBP and GFR was affected by findings on surveillance biopsy, we examined the relationship between percentage of nocturnal fall in SBP and GFR separately in those with normal or abnormal biopsies. A total of 112 recipients had surveillance allograft biopsies at 1 yr of follow-up. For the purpose of this analysis, biopsies were classified into four groups: Normal (n ϭ 48), chronic allograft nephropathy (CAN; n ϭ 45; 32 were grade 1, 11 were grade 2, and two were grade 3), biopsies with inflammation (n ϭ 12; four showed acute cellular rejection [three Banff 1A and 1 Banff 1B], two borderline rejection, four interstitial nephritis, and two PVAN), and biopsies with glomerular disease (n ϭ 7; four had transplant glomerulopathy, two had FSGS, and one had membranous nephropathy). The day-night fall in SBP and the proportion of dippers were similar between those with CAN and those with normal histologic findings, indicating that dipper status was not related to allograft fibrosis. Similarly, the proportion of dippers was not different in those with biopsy evidence of inflammation or transplant glomerulopathy. Of the 48 patients with normal biopsies, 47 had iothalamate clearance available at both 3 wk and 1 yr after transplantation. None of these recipients experienced acute rejection, whereas one recipient developed PVAN that cleared during the course of the first year. Kidney transplant recipients with normal histologic findings demonstrated a direct correlation between day-night SBP change and cv score on surveillance biopsy (R ϭ 0.4, P ϭ 0.002). 
52 (43) a BMI, body mass index.
Importantly, there was also a direct correlation between day-night SBP change and GFR at 1 yr (R ϭ 0.4, P ϭ 0.006; Figure 3 ). No such relationship was evident in the 3-wk measurement of GFR (R ϭ 0.2; NS). Other factors that affected 1-yr GFR included GFR 3 wk after transplantation, diabetes, donor age, and RI. On multivariate analysis, dismissal GFR was the only predictor of 1-yr function. Because early GFR may relate to late (1 yr) GFR, 3-wk GFR was excluded from the regression model. After exclusion of 3-wk GFR, percentage of nocturnal fall in SBP (P ϭ 0.006) and RI (P ϭ 0.068) were independently related to 1-yr GFR ( 
a AR, acute rejection; DBP, diastolic BP; i ϩ t and ci ϩ ct, acute and chronic scores for inflammation and tubular injury; PVAN, polyomavirus-associated nephropathy; RI, resistive index; SBP, systolic BP. strated CAN, inflammation, or glomerular disease, likely reflecting the detrimental effect of the underlying pathology on GFR (R ϭ 0.2, P ϭ 0.14).
Discussion
The results of our study both identify correlates of abnormal day-night BP change and relate these measurements to allograft function and histology 1 yr after transplantation in 119 kidney transplant recipients. The majority of these patients were receiving antihypertensive medications, with 85 (71%) achieving target BP levels. Older recipients, presence of diabetes, high cv score, and elevated RI tended to associate with abnormal circadian BP rhythms. Nocturnal fall in SBP and GFR were related with worse allograft function in those with abnormal circadian BP change. These changes were most evident in those with a paradoxic rise in nocturnal BP. Perhaps most important, recipients with normal allograft histology at 1 yr after transplantation demonstrated a direct correlation between the percentage of nocturnal fall in SBP and GFR as measured by iothalamate clearance. Doppler-derived RI was also independently related to iothalamate clearance, indicating that there is a relationship among diurnal BP pattern, GFR, cv changes, and elevated RI independent of allograft fibrosis.
Our results extend previous observations from reports that studied ABPM in kidney transplant recipients who were maintained mainly on cyclosporine-based immunosuppression. These reports indicated a prevalence of abnormal diurnal variation that ranged from 25 to 100% (10, (22) (23) (24) . For some of these reports, disturbances in day-night change in SBP are related to cyclosporine dosage and poor allograft function (25) (26) (27) . A recent study by Covic et al. (22) identified an abnormal BP pattern in all 20 studied cyclosporine-treated and rejection-free kidney transplant recipients without diabetes 1 mo after transplant who later normalized the BP pattern in eight (40%) by 1 yr. These authors attributed the recovery of diurnal pattern to the reduction in immunosuppression level. The prevalence of abnormal day-night BP pattern in tacrolimus-treated kidney transplant patients has not been examined in large series. Our results indicated that abnormal BP diurnal variation was common, affecting 75% of tacrolimus-treated kidney transplant re- cipients who otherwise had stable allograft function 1 yr after transplantation. Our findings also indicated that the average trough tacrolimus level did not relate to the day-night BP pattern, unlike reports from cyclosporine-based regimens.
Whether the use of calcineurin inhibitor-free and/or steroid free immunosuppression protocols will favorably affect the diurnal SBP pattern in transplant recipients has not been tested and merits evaluation in future trials.
Older age is associated with lack of normal nocturnal fall in SBP in kidney transplant recipients (10) . In addition to recipient's age, our study identified diabetes, elevated RI, and lower GFR as correlates of abnormal day-night SBP change. The finding that nondipper status is associated with diabetes is recognized as a feature of autonomic dysfunction, regardless of renal function (28) . Although the relationship between diabetes and abnormal BP pattern did not reach statistical significance in this study (P ϭ 0.06), this is probably because of the small sample size. RI is promoted as a general marker of vascular compliance (13, 14) . An elevated RI is associated with older recipient age and increased pulse pressure and is a predictor of renal allograft survival and death from cardiovascular disease (13, 15, 16, 29) . The correlation between elevated RI and lack of nocturnal fall in SBP in our cohort has at least two possible explanations. First, loss of normal day-night BP change may be a manifestation of decreased vascular compliance as evidenced by elevated RI. Alternatively, identified (old age, increased pulse pressure, low GFR) or unidentified factors may be simultaneously responsible for both abnormal diurnal BP pattern and elevated RI. We cannot distinguish which one of these explanations is operative, but we interpret our results to demonstrate that loss of normal SBP diurnal variation and elevated RI are related. Remarkably, RI was similar between patients with normal and pathologic biopsies with early CAN and had no evident correlation with the Banff '97 acuity or chronicity indices (data not shown). These results indicated that elevated RI in our patients was not necessarily a reflection of parenchymal renal injury but rather was a reflection of vascular disease Figure 1 . Relationship between 1-yr iothalamate clearance and dipper status: Plot of the iothalamate GFR for dippers, nondippers, and reverse dippers. GFR progressively declined in nondippers and reverse dippers compared with dippers (P ϭ 0.04). For each group, the GFR mean Ϯ SD is provided. primarily. This interpretation is supported by previous studies that showed no correlation between high RI and protocol biopsy findings in 87 kidney transplant recipients (16). Heine et al. (30, 31) documented a direct relationship between elevated RI and subclinical extrarenal atherosclerotic vascular disease in both kidney transplant recipients and patients with CKD. Regardless of the interpretation, our study identified elevated RI as an independent predictor of GFR 1 yr after transplantation in recipients with normal histologic findings and with no history of rejection. This observation highlights the potential importance of elevated RI in identifying a group of transplant patients who are at risk for early loss of kidney function and might benefit from therapeutic interventions, possibly directed toward improving vascular compliance (32) . Is the loss of circadian BP rhythm a pathogenic factor involved in allograft function loss? Loss of circadian BP changes has been linked to target organ damage and accelerated kidney function loss in hypertensive patients with and without CKD (9, 33, 34) . Although uncontrolled systemic hypertension is related to poor allograft and patient survival after kidney transplantation, loss of normal nocturnal fall in SBP, independent of BP control, has not been fully defined as a promoter of kidney function attrition after transplantation (2, 35, 36) . Haydar et al. (37) studied the role of ABPM-derived BP values that were obtained at 2 to 34 wk after transplantation in predicting renal function decline in 177 kidney transplant recipients. After 48 to 287 wk of follow-up, last serum creatinine correlated only with early transplant kidney function with no observed difference between dippers and nondippers. Although the results are consistent with lack of a protective effect of a dipper status, it should be noted that the time points at which ABPM was obtained as well as the follow-up periods were widely variable between patients. Moreover, serum creatinine rather than GFR was used for allograft monitoring. Our results indicate that nondipper status and reverse dipper status confer worse allograft function at 1 yr from transplantation in this homogeneously monitored group of patients with ABPM and iothalamate clearance obtained at a fixed time point after transplantation. Moreover, the percentage of nocturnal fall in SBP was an independent correlate to 1-yr GFR, especially in recipients with normal allograft histology. Our data cannot establish whether the nocturnal rise in SBP is itself the injurious factor or patients who develop poor allograft function manifest first with loss of circadian change in SBP. However, the finding of more pronounced vascular injury as indicated by higher RI and a trend toward a higher cv score (P ϭ 0.07) in nondippers and reverse dippers makes us hypothesize that lack of nocturnal fall in SBP has a detrimental effect on allograft function, at least in recipients with normal histology. It is also noteworthy to mention that awake SBP obtained by different BP measurement techniques did not relate directly to allograft GFR at this early time point. These data support the contention that ABPM should be a preferred method to evaluate systemic hypertension in kidney transplant patients and that its benefits extend beyond the diagnosis of hypertension or monitoring antihypertensive therapy. Whether implementing protocols that are targeted directly to control nighttime hypertension or identifying and treating other factors that induce nocturnal hypertension (e.g., sleep apnea) will confer functional benefit is an important question that merits consideration in future trials. Our study represents the largest comprehensive series to date that correlates ABPM values with allograft kidney function, histologic changes, and ultrasound findings. It must be recognized that our data are limited to the studied population, which consisted mainly of white patients who received livingdonor kidney transplants. The population that was selected for review comprised a consecutive group of kidney transplant recipients without evident selection bias. The clinical features, pretransplantation diagnosis, and immunosuppression were consistent with other temporal cohorts from our institution (38 -40) . We also sampled a period in our practice during which the annual follow-up was homogeneous and consistent among patients. These data provide information regarding the relationships between diurnal BP measurements and early allograft structure and function. Whether such relationships will extend to long-term injury or progressive allograft dysfunction is an important question that cannot be addressed with this study.
Conclusion
Taken together, our results identified a relationship between loss of nocturnal fall in SBP and low GFR, increased cv score, and high RI 1 yr after transplantation. These findings suggest that in addition to immunologic injury and early allograft fibrosis, nocturnal hypertension can be added as cause of early allograft dysfunction. Therapeutic measures that aim to diagnose and treat abnormal BP diurnal variation in kidney transplant patients are needed to determine whether normalization of the BP pattern will translate into functional or survival benefit.
